Comparison
8p11 2 Deletion Syndrome C4304505 vs Abca4 Related Retinopathy CN322612
Clinical comparison between 8p11 2 Deletion Syndrome and Abca4 Related Retinopathy CN322612 for differential diagnosis and treatment planning.
8p11 2 Deletion Syndrome C4304505
A genetic condition caused by deletion of material from chromosome 8. It may lead to developmental delays, distinctive facial features, and other health concerns. Treatment focuses on addressing specific symptoms with multidisciplinary support.
Abca4 Related Retinopathy CN322612
6 comparison axes
Onset
8p11 2 Deletion Syndrome C4304505
0-null
Abca4 Related Retinopathy CN322612
5-60
Onset patterns differ
Severity
8p11 2 Deletion Syndrome C4304505
moderate
Abca4 Related Retinopathy CN322612
moderate
Different severity levels
Chronic
8p11 2 Deletion Syndrome C4304505
Chronic
Abca4 Related Retinopathy CN322612
Chronic
Differing course
Communicable
8p11 2 Deletion Syndrome C4304505
No
Abca4 Related Retinopathy CN322612
No
Different transmission
Body System
8p11 2 Deletion Syndrome C4304505
congenital
Abca4 Related Retinopathy CN322612
ophthalmologic
Same/different system
Category
8p11 2 Deletion Syndrome C4304505
genetic
Abca4 Related Retinopathy CN322612
genetic
Different category
Bottom line
8p11-2-deletion-syndrome-C4304505 and abca4-related-retinopathy-CN322612 have similar characteristics
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 8p11 2 Deletion Syndrome C4304505 | Abca4 Related Retinopathy CN322612 | Discriminating power |
|---|---|---|---|
| Development | Developmental delay and congenital concerns may occur. | Developmental effects are not established in the supplied data. | High |
| Vision | Eye disease is not described as defining. | Retinal dysfunction is the core concern; exact symptoms are unspecified. | High |
| Congenital features | Distinctive facial features may be present. | No congenital facial phenotype is established here. | Moderate |
When to favor each condition
Choose 8p11 2 Deletion Syndrome C4304505 when
Developmental delay with suspected chromosomal deletion
The left concept is a congenital chromosome 8 deletion syndrome.
High
Need for multisystem developmental support
Care is described as symptom-directed and multidisciplinary.
Moderate
Congenital-anomaly classification context
Q89.9 is assigned, but a code alone does not confirm the diagnosis.
Moderate
Choose Abca4 Related Retinopathy CN322612 when
Suspected inherited retinal disease
The supplied axis places it in the ophthalmologic system, onset ages 5–60.
Moderate
Evaluation centered on ABCA4
The concept name implies ABCA4 association; phenotype details are not supplied.
Moderate
Predominant visual symptoms without congenital syndrome features
It is not described as a broad multisystem congenital syndrome.
Moderate
How key tests differ
| Test | 8p11 2 Deletion Syndrome C4304505 | Abca4 Related Retinopathy CN322612 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | May identify material deleted at 8p11.2. | Not the defining test for ABCA4 retinopathy. | A relevant deletion supports the left concept but requires clinical correlation. |
| ABCA4 genetic testing | Not described as diagnostic for this syndrome. | Pathogenic variants may support the named disorder. | A variant alone is not a diagnosis without compatible retinal findings. |
| Retinal imaging or electrophysiology | No specific result is established in the source. | May show retinal dysfunction; no cutoff is supplied. | An abnormal test indicates a finding, not automatically a specific diagnosis. |
Prognosis comparison
8p11 2 Deletion Syndrome C4304505
- Outcome
- Variable chronic course; mortality and exact outcomes are not established.
- Factors
- Deletion extent, involved organs, developmental needs, and support access.
Abca4 Related Retinopathy CN322612
- Outcome
- Chronic retinal disease with variable visual outcome; rates are not supplied.
- Factors
- Genotype, onset age, retinal involvement, and follow-up, details unspecified.
Time frame: Both may be lifelong; cited retinopathy onset spans ages 5–60.
Individual findings outweigh shared chronic, genetic, and moderate labels.
Complications comparison
| Complication | Presentation |
|---|---|
| Learning or developmental difficulty | May be a major clinical concern. Not established from the supplied data. Do not assume equivalent cognitive impact. |
| Progressive vision impairment | Not described as typical. A clinically important possibility, with variable severity. Rates and exact course are not established here. |
| Long-term specialist needs | Genetics, development, and symptom-specific services. Ophthalmology and genetic counseling. Both are chronic, but the care teams differ. |
Patient education highlights
- HighDistinct conditions
Similar genetic and moderate labels do not mean these are the same disease.
- HighTests versus diagnosis
Chromosome or retinal results need clinician review before diagnosis.
- MediumCare planning
Ask about monitoring, specialists, and family counseling; no treatment dose is established here.